3721 - 3730 of 8819 Results
Title
Year
-
RESTRICTEDTitle: Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson’s diseaseJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 29Issue #: 6Start Page: 603End Page: 614Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10286-019-00632-wBest OA location URL: https://escholarship.org/content/qt5zh861v7/qt5zh861v7.pdf?t=qa7xspCitation Count: 16
-
OPENTitle: Reversible Conformational Conversion of α-Synuclein into Toxic Assemblies by GlucosylceramideJournal Name: NeuronPublisher: Elsevier BVVol: 97Issue #: 1Start Page: 92End Page: 107.e10Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuron.2017.12.012Best OA location URL: http://www.cell.com/article/S0896627317311352/pdfCitation Count: 195
-
OPENTitle: Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitorsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 5Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.17111Best OA location URL: https://doi.org/10.7554/elife.17111Citation Count: 55
- The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease2017RESTRICTEDTitle: The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 291Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2017.01.012Best OA location URL: http://www.sciencedirect.com/science/article/pii/S0014488617300213?via%3DihubCitation Count: 24
- Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects2014OPENTitle: Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjectsJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 571Issue #:Start Page: 34End Page: 38Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2014.04.027Best OA location URL: http://doi.org/10.1016/j.neulet.2014.04.027Citation Count: 130
-
OPENTitle: Novel Thienopyrimidine-Based PET Tracers for P2Y12 Receptor Imaging in the BrainJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 12Issue #: 23Start Page: 4465End Page: 4474Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acschemneuro.1c00641Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8640995Citation Count: 26
-
RESTRICTEDTitle: Media hype: Patient and scientific perspectives on misleading medical newsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 9Start Page: 1319End Page: 1323Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26993Citation Count: 44
-
OPENTitle: Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson’s Disease in RodentsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 8Issue #: 2Start Page: 303End Page: 322Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-171248Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd171248?id=journal-of-parkinsons-disease%2Fjpd171248Citation Count: 234
-
OPENTitle: Oligomeric α‐synuclein and β‐amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseasesJournal Name: European Journal of NeurosciencePublisher: WileyVol: 43Issue #: 1Start Page: 3End Page: 16Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ejn.13056Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.13056Citation Count: 68
- The E3 Ubiquitin Ligases TRIM17 and TRIM41 Modulate α-Synuclein Expression by Regulating ZSCAN212018OPENTitle: The E3 Ubiquitin Ligases TRIM17 and TRIM41 Modulate α-Synuclein Expression by Regulating ZSCAN21Journal Name: Cell ReportsPublisher: Elsevier BVVol: 25Issue #: 9Start Page: 2484End Page: 2496.e9Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2018.11.002Best OA location URL: http://www.cell.com/article/S2211124718317315/pdfCitation Count: 36